Article
Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients.
World journal of surgical oncology - 4 Dec 2020
Zhan Yu, Wu Xueyuan, Zheng Gang, Jin Jingjing, Li Chaofu, Yu Guanzhen, Li Wenfeng
Abstract excerpt
BACKGROUND: The proline-rich protein 11 (PRR11) is a newly identified oncogene associated with a poor prognosis in several human cancers. Nonetheless, research on its role in ovarian cancer (OC) remains largely understudied. Therefore, this study aims to evaluate the expression levels of PRR11 protein and its role in human ovarian cancer. METHODS: Immunohistochemistry analysis was used to evaluate the expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
